On-demand biomanufacturing through synthetic biology approach
Biopharmaceuticals including protein therapeutics, engineered protein-based vaccines and monoclonal antibodies, are currently the mainstay products of the biotechnology industry. However, the need for specialized equipment and refrigeration during production and distribution poses challenges for the...
Saved in:
Published in | Materials today bio Vol. 18; p. 100518 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Biopharmaceuticals including protein therapeutics, engineered protein-based vaccines and monoclonal antibodies, are currently the mainstay products of the biotechnology industry. However, the need for specialized equipment and refrigeration during production and distribution poses challenges for the delivery of these technologies to the field and low-resource area. With the development of synthetic biology, multiple studies rewire the cell-free system or living cells to impact the portable, on-site and on-demand manufacturing of biomolecules. Here, we review these efforts and suggest future directions.
On demand biomanufacturing. In this review, we summarize approaches that consisting of cell-free protein synthesis (CFPS) and living cellular hosts to achieve the on demand biomanufacturing of vaccines, antibodies, enzymes, proteins or small molecules drugs. [Display omitted] |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contribute equally. |
ISSN: | 2590-0064 2590-0064 |
DOI: | 10.1016/j.mtbio.2022.100518 |